Balkan Medical Journal最新文献

筛选
英文 中文
Secukinumab-Induced Interstitial Pneumonia in a Patient with Psoriasis. 银屑病患者致间质性肺炎1例。
IF 3.8 4区 医学
Balkan Medical Journal Pub Date : 2025-10-02 DOI: 10.4274/balkanmedj.galenos.2025.2025-8-43
Siqi Li, Ru Dai, Qunye Xu
{"title":"Secukinumab-Induced Interstitial Pneumonia in a Patient with Psoriasis.","authors":"Siqi Li, Ru Dai, Qunye Xu","doi":"10.4274/balkanmedj.galenos.2025.2025-8-43","DOIUrl":"https://doi.org/10.4274/balkanmedj.galenos.2025.2025-8-43","url":null,"abstract":"","PeriodicalId":8690,"journal":{"name":"Balkan Medical Journal","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145205484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fat Mass and Obesity-Associated Protein-Mediated Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Promotes Chemotherapy Resistance in Acute Myeloid Leukemia. 脂肪量和肥胖相关蛋白介导的骨髓间充质干细胞成脂分化促进急性髓系白血病化疗耐药
IF 3.8 4区 医学
Balkan Medical Journal Pub Date : 2025-10-02 DOI: 10.4274/balkanmedj.galenos.2025.2025-7-150
Pan Zhipeng, Kang Lixia, Chen Ling
{"title":"Fat Mass and Obesity-Associated Protein-Mediated Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Promotes Chemotherapy Resistance in Acute Myeloid Leukemia.","authors":"Pan Zhipeng, Kang Lixia, Chen Ling","doi":"10.4274/balkanmedj.galenos.2025.2025-7-150","DOIUrl":"https://doi.org/10.4274/balkanmedj.galenos.2025.2025-7-150","url":null,"abstract":"<p><strong>Background: </strong>Chemotherapy resistance and relapse in acute myeloid leukemia (AML) are associated with poor prognosis. Bone marrow mesenchymal stem cells (MSCs) show enhanced adipogenic differentiation in AML, which may contribute to chemoresistance; however, the underlying mechanisms remain incompletely understood.</p><p><strong>Aims: </strong>To investigate how adipogenic differentiation of MSCs from chemotherapy-resistant AML patients (CR-AML-MSCs) promotes chemoresistance, focusing on the roles of the fat mass and obesity-associated protein (FTO) and the mTORC1 pathway.</p><p><strong>Study design: </strong>Experimental study.</p><p><strong>Methods: </strong>This study compared bone marrow MSCs from chemotherapy-sensitive (CS) and CR AML patients. Adipogenic differentiation was assessed using Oil Red O staining. RNA sequencing, qPCR, and western blotting were employed to analyze expression of FTO, Raptor, and PPARγ. Global m<sup>6</sup>A levels were measured, and co-culture models with AML cell lines (U937, HL-60, THP-1) were established to evaluate chemoresistance. Gain- and loss-of-function experiments for FTO were performed using lentiviral overexpression and shRNA knockdown. mTORC1 pathway involvement was tested using rapamycin. Statistical analyses included t-tests and ANOVA, with significance set at (<i>p</i> < 0.05). MSCs from chemotherapy-sensitive and resistant AML patients were compared. Adipogenic differentiation was induced and assessed by Oil Red O staining. RNA sequencing, qPCR, and western blotting were used to analyze the expression of FTO, Raptor, and PPARγ. Global m<sup>6</sup>A levels were measured, and co-culture models with AML cell lines (U937, HL-60, THP-1) were established to evaluate chemoresistance. Gain- and loss-of-function experiments for FTO were performed.</p><p><strong>Results: </strong>CR-AML-MSCs exhibited significantly enhanced adipogenic differentiation (<i>p</i> < 0.01) and elevated PPARγ expression. Co-culture with adipocyte-differentiated CR-AML-MSCs markedly increased resistance to daunorubicin and cytarabine in AML cells (<i>p</i> < 0.01). RNA-Seq analysis revealed enrichment of the mTORC1 signaling pathway and upregulation of raptor. Inhibition of mTORC1 with rapamycin suppressed adipogenic differentiation. Total m<sup>6</sup>A levels were reduced in CR-AML-MSCs, whereas FTO expression was increased. Overexpression of FTO further promoted adipogenesis, upregulated raptor and PPARγ, and enhanced chemoresistance, whereas FTO knockdown attenuated these effects.</p><p><strong>Conclusion: </strong>FTO enhances adipogenic differentiation of CR-AML-MSCs through m<sup>6</sup>A demethylation of raptor, leading to mTORC1 pathway activation and subsequent chemoresistance. These findings reveal a novel mechanism underlying AML chemoresistance and suggest potential therapeutic targets.</p>","PeriodicalId":8690,"journal":{"name":"Balkan Medical Journal","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145205378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factor XI/XIa Inhibitors: Promising Agents for the Secondary Prevention of Ischemic Stroke. 因子XI/XIa抑制剂:缺血性卒中二级预防的有希望的药物。
IF 3.8 4区 医学
Balkan Medical Journal Pub Date : 2025-09-26 DOI: 10.4274/balkanmedj.galenos.2025.2025.160925
Murat Mert Atmaca
{"title":"Factor XI/XIa Inhibitors: Promising Agents for the Secondary Prevention of Ischemic Stroke.","authors":"Murat Mert Atmaca","doi":"10.4274/balkanmedj.galenos.2025.2025.160925","DOIUrl":"https://doi.org/10.4274/balkanmedj.galenos.2025.2025.160925","url":null,"abstract":"","PeriodicalId":8690,"journal":{"name":"Balkan Medical Journal","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cystic Bronchiectasis due to AIDS: Case, and References. 艾滋病引起的囊性支气管扩张:病例和参考文献。
IF 3.8 4区 医学
Balkan Medical Journal Pub Date : 2025-09-25 DOI: 10.4274/balkanmedj.galenos.2025.2025-8-80
Songyang Pan, Miao Chen, Tianyang Dai
{"title":"Cystic Bronchiectasis due to AIDS: Case, and References.","authors":"Songyang Pan, Miao Chen, Tianyang Dai","doi":"10.4274/balkanmedj.galenos.2025.2025-8-80","DOIUrl":"https://doi.org/10.4274/balkanmedj.galenos.2025.2025-8-80","url":null,"abstract":"","PeriodicalId":8690,"journal":{"name":"Balkan Medical Journal","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145136192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Important Feature of Gastric Adenocarcinoma: Heterogeneous Microsatellite Status. 胃腺癌的一个重要特征:异质性微卫星状态。
IF 3.8 4区 医学
Balkan Medical Journal Pub Date : 2025-09-24 DOI: 10.4274/balkanmedj.galenos.2025.2025-7-281
Mirac Ajredini, Arda Ulaş Mutlu, Sibel Erdamar Çetin, Rümeysa Atabey, Erman Aytaç, Leyla Özer
{"title":"An Important Feature of Gastric Adenocarcinoma: Heterogeneous Microsatellite Status.","authors":"Mirac Ajredini, Arda Ulaş Mutlu, Sibel Erdamar Çetin, Rümeysa Atabey, Erman Aytaç, Leyla Özer","doi":"10.4274/balkanmedj.galenos.2025.2025-7-281","DOIUrl":"https://doi.org/10.4274/balkanmedj.galenos.2025.2025-7-281","url":null,"abstract":"","PeriodicalId":8690,"journal":{"name":"Balkan Medical Journal","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145130033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uric Acid-Lowering Therapy with Febuxostat in Patients with Chronic Heart Failure and Hyperuricemia: A Prospective and Observational Cohort Study. 非布司他降尿酸治疗慢性心力衰竭和高尿酸血症患者:一项前瞻性和观察性队列研究。
IF 3.8 4区 医学
Balkan Medical Journal Pub Date : 2025-09-22 DOI: 10.4274/balkanmedj.galenos.2025.2025-6-168
Jiahan Ke, Xiaohan Qiu, Min Wang, Huasu Zeng, Changqian Wang, Junfeng Zhang, Huafang Zhu, Jun Gu
{"title":"Uric Acid-Lowering Therapy with Febuxostat in Patients with Chronic Heart Failure and Hyperuricemia: A Prospective and Observational Cohort Study.","authors":"Jiahan Ke, Xiaohan Qiu, Min Wang, Huasu Zeng, Changqian Wang, Junfeng Zhang, Huafang Zhu, Jun Gu","doi":"10.4274/balkanmedj.galenos.2025.2025-6-168","DOIUrl":"https://doi.org/10.4274/balkanmedj.galenos.2025.2025-6-168","url":null,"abstract":"<p><strong>Background: </strong>Hyperuricemia is associated with poor clinical outcomes in several cardiovascular diseases, including heart failure (HF). However, whether lowering serum uric acid (SUA) levels improves the prognosis of HF remains insufficiently studied.</p><p><strong>Aims: </strong>To evaluate whether urate-lowering therapy (ULT) with febuxostat confers clinical benefits in patients with HF and concomitant hyperuricemia.</p><p><strong>Study design: </strong>Prospective, observational cohort study.</p><p><strong>Methods: </strong>Patients with chronic HF and hyperuricemia were enrolled and assigned either to a febuxostat group or to a non-ULT group and were followed prospectively for 5 years. The primary endpoint was all-cause mortality or rehospitalization for HF.</p><p><strong>Results: </strong>Among 2005 patients, those with higher SUA levels experienced more endpoint events. After propensity score matching, we found that febuxostat therapy significantly reduced the incidence of primary endpoints in patients with HFwith preserved ejection fraction (HFpEF) [<i>p</i> = 0.012; hazard ratios (HR), 0.744; 95% confidence intervals (CI), 0.589-0.939], but not in those with HF with reduced ejection fraction (HFrEF) or mildly reduced ejection fraction (HFmrEF) (<i>p</i> = 0.234; HR, 0.894; 95% CI, 0.742-1.077). The benefits of febuxostat in HFpEF were most evident in patients within the highest tertiles of B-type natriuretic peptide (BNP) (<i>p</i> = 0.021; HR, 0.647; 95% CI, 0.436-0.960) and SUA (<i>p</i> = 0.025; HR, 0.651; 95% CI, 0.441-0.963).</p><p><strong>Conclusion: </strong>High SUA levels are associated with increased all-cause mortality and rehospitalization for HF. Febuxostat-mediated SUA reduction significantly improved clinical outcomes in patients with HFpEF, particularly those with elevated SUA and BNP levels.</p>","PeriodicalId":8690,"journal":{"name":"Balkan Medical Journal","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145111888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung Metastatic Ameloblastoma: A Hidden Cause of Pulmonary Nodules. 肺转移性成釉细胞瘤:肺结节的隐藏原因。
IF 3.8 4区 医学
Balkan Medical Journal Pub Date : 2025-09-12 DOI: 10.4274/balkanmedj.galenos.2025.2025-8-6
İrem Karaman, Barış Hekimoğlu, Mürüvvet Akçay Çelik, Dilek Erdem, Şevket Özkaya
{"title":"Lung Metastatic Ameloblastoma: A Hidden Cause of Pulmonary Nodules.","authors":"İrem Karaman, Barış Hekimoğlu, Mürüvvet Akçay Çelik, Dilek Erdem, Şevket Özkaya","doi":"10.4274/balkanmedj.galenos.2025.2025-8-6","DOIUrl":"https://doi.org/10.4274/balkanmedj.galenos.2025.2025-8-6","url":null,"abstract":"","PeriodicalId":8690,"journal":{"name":"Balkan Medical Journal","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145038987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External Manual Carotid Compression for Cavernous Sinus Fistula. 手工颈动脉外压治疗海绵窦瘘。
IF 3.8 4区 医学
Balkan Medical Journal Pub Date : 2025-09-08 DOI: 10.4274/balkanmedj.galenos.2025.2025-5-157
Xiaoxin Ji, Wei Su, Shancheng Si
{"title":"External Manual Carotid Compression for Cavernous Sinus Fistula.","authors":"Xiaoxin Ji, Wei Su, Shancheng Si","doi":"10.4274/balkanmedj.galenos.2025.2025-5-157","DOIUrl":"https://doi.org/10.4274/balkanmedj.galenos.2025.2025-5-157","url":null,"abstract":"","PeriodicalId":8690,"journal":{"name":"Balkan Medical Journal","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145013827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can SGLT2 Inhibitors Prevent Atrial Fibrillation in HFpEF? SGLT2抑制剂能预防HFpEF患者心房颤动吗?
IF 3.8 4区 医学
Balkan Medical Journal Pub Date : 2025-09-03 DOI: 10.4274/balkanmedj.galenos.2025.2025-6-248
Bülent Özlek
{"title":"Can SGLT2 Inhibitors Prevent Atrial Fibrillation in HFpEF?","authors":"Bülent Özlek","doi":"10.4274/balkanmedj.galenos.2025.2025-6-248","DOIUrl":"10.4274/balkanmedj.galenos.2025.2025-6-248","url":null,"abstract":"","PeriodicalId":8690,"journal":{"name":"Balkan Medical Journal","volume":" ","pages":""},"PeriodicalIF":3.8,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144940400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differentiating Pectus Excavatum-Related Right Ventricul Dysfunction from ARVD: The Role of Cardiac Imaging 鉴别凹胸肌相关的右心室功能障碍与ARVD:心脏成像的作用。
IF 3.8 4区 医学
Balkan Medical Journal Pub Date : 2025-09-01 Epub Date: 2025-07-08 DOI: 10.4274/balkanmedj.galenos.2025.2025-3-133
Özge Özden Kayhan, Cemre Turgul, Çağla Akçay Ürkmez, Gökhan Aksan, Haşim Tüner
{"title":"Differentiating Pectus Excavatum-Related Right Ventricul Dysfunction from ARVD: The Role of Cardiac Imaging","authors":"Özge Özden Kayhan, Cemre Turgul, Çağla Akçay Ürkmez, Gökhan Aksan, Haşim Tüner","doi":"10.4274/balkanmedj.galenos.2025.2025-3-133","DOIUrl":"10.4274/balkanmedj.galenos.2025.2025-3-133","url":null,"abstract":"","PeriodicalId":8690,"journal":{"name":"Balkan Medical Journal","volume":" ","pages":"473-474"},"PeriodicalIF":3.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12402957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144582943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信